naringenin has been researched along with Bleeding in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatziathanasiadou, MV; Deligianni, M; Kellici, TF; Kostagianni, AD; Stylos, E; Tselepis, AD; Tsiailanis, A; Tsoumani, M; Tzakos, AG | 1 |
1 other study(ies) available for naringenin and Bleeding
Article | Year |
---|---|
Tailoring naringenin conjugates with amplified and triple antiplatelet activity profile: Rational design, synthesis, human plasma stability and in vitro evaluation.
Topics: Aspirin; Cardiovascular Diseases; Computer Simulation; Cyclooxygenase 1; Docosahexaenoic Acids; Flavanones; Flavonoids; Hemorrhage; Humans; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptor, PAR-1; Receptors, Purinergic P2Y12; Signal Transduction; Standard of Care; Tandem Mass Spectrometry | 2017 |